Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Viracept nelfinavir regulatory update

PFE issued a "Dear Healthcare Professional" letter to warn of the presence of ethyl methanesulfonate (EMS), a process-related impurity

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE